CORRADINI, PAOLO
CORRADINI, PAOLO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
The impact of starting dose on overall survival in myelofibrosis patients treated with ruxolitinib: A prospective real-world study on AIFA monitoring registries
2024 M. Breccia, S. Celant, F. Palandri, F. Passamonti, P.P. Olimpieri, V. Summa, A. Guarcello, G.A. Palumbo, F. Pane, P. Guglielmelli, P. Corradini, P. Russo
Role of bridging RT in relapsed/refractory diffuse large B-cell lymphoma undergoing CAR-T therapy: a multicenter study
2024 S. Bramanti, D. Mannina, A. Chiappella, B. Casadei, C. De Philippis, L. Giordano, P. Navarria, P. Mancosu, D. Taurino, M. Scorsetti, C. Carlo-Stella, P. Zinzani, A. Santoro, P. Corradini
A Multicenter Real-life Prospective Study of Axicabtagene Ciloleucel versus Tisagenlecleucel Toxicity and Outcomes in Large B-cell Lymphomas
2024 F. Stella, A. Chiappella, B. Casadei, S. Bramanti, S. Ljevar, P. Chiusolo, A. Di Rocco, M.C. Tisi, M.G. Carrabba, I. Cutini, M. Martino, A. Dodero, F. Bonifazi, A. Santoro, F. Sorà, B. Botto, A.M. Barbui, D. Russo, M. Musso, G. Grillo, M. Krampera, J. Olivieri, M. Ladetto, F. Cavallo, M. Massaia, L. Arcaini, M. Pennisi, P.L. Zinzani, R. Miceli, P. Corradini
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma
2024 B. Ziccheddu, C. Giannotta, M. D'Agostino, G. Bertuglia, E. Saraci, S. Oliva, E. Genuardi, M. Papadimitriou, B. Diamond, P. Corradini, D. Coffey, O. Landgren, N. Bolli, B. Bruno, M. Boccadoro, M. Massaia, F. Maura, A. Larocca
Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study
2024 A. Chiappella, B. Casadei, P. Chiusolo, A. Di Rocco, S. Ljevar, M. Magni, P. Angelillo, A.M. Barbui, I. Cutini, A. Dodero, F. Bonifazi, M.C. Tisi, S. Bramanti, M. Musso, M. Farina, M. Martino, M. Novo, G. Grillo, F. Patriarca, G. Zacchi, M. Krampera, M. Pennisi, E. Galli, M. Martelli, A.J.M. Ferreri, S. Ferrari, R. Saccardi, A. Bermema, A. Guidetti, R. Miceli, P.L. Zinzani, P. Corradini
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial
2024 G. Cavallaro, A. Grassi, C. Pavoni, M.C. Micò, A. Busca, I.M. Cavattoni, S. Santarone, C. Borghero, A. Olivieri, G. Milone, P. Chiusolo, P. Musto, R. Saccardi, F. Patriarca, F. Pane, G. Saporiti, P. Rivela, E. Terruzzi, R. Cerretti, G. Marotta, A.M. Carella, A. Nagler, D. Russo, P. Corradini, P. Bernasconi, A.P. Iori, L. Castagna, N. Mordini, E. Oldani, C. Di Grazia, A. Bacigalupo, A. Rambaldi
Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial
2024 A. Pulsoni, S. Ferrero, M.E. Tosti, S. Luminari, A. Dondi, F. Cavallo, F. Merli, A.M. Liberati, N. Cenfra, D. Renzi, M. Zanni, C. Boccomini, A.J.M. Ferreri, S. Rattotti, V.R. Zilioli, S.A. Bolis, P. Bernuzzi, G. Musuraca, G. Gaidano, T. Perrone, C. Stelitano, A. Tucci, P. Corradini, S. Bigliardi, F. Re, E. Cencini, C. Mannarella, D. Mannina, M. Celli, M. Tani, G. Annechini, G.M. Assanto, L. Grapulin, A. Guarini, M. Cavalli, L.A. De Novi, R. Bomben, E. Ciabatti, E. Genuardi, D. Drandi, I. Della Starza, L. Arcaini, U. Ricardi, V. Gattei, S. Galimberti, M. Ladetto, R. Foà, I. Del Giudice
Secondary primary malignancies after CD-19 directed CAR-T-cell therapy in lymphomas: A report from the Italian CART-SIE study
2024 A. Barone, A. Chiappella, B. Casadei, S. Bramanti, S. Ljevar, P. Chiusolo, A. Di Rocco, M.C. Tisi, A.M. Barbui, M. Farina, L. Brunello, M.C. Di Chio, M. Novo, M. Musso, J. Olivieri, G.E. Trotta, A. Dodero, A. Aiello, P. Corradini
Towards a personalized preventive strategy of Herpes zoster infection in patients with hematologic diseases or hematopoietic stem cell transplant recipients: a position paper from an ad hoc Italian expert panel
2023 C. Girmenia, F. Ciceri, P. Corradini, A. Cuneo, F. D'Ancona, P. Musto, A.M. Risitano, M.T. Voso, A. Venditti, G. Barosi
A prospective, multicenter study on hematopoietic stem-cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor and 'on-demand' plerixafor in multiple myeloma patients treated with novel agents
2023 R. Mina, M.T. Petrucci, F. Bonello, V. Bongarzoni, R. Saccardi, G. Bertuglia, A. Mengarelli, A. Spadaro, C. Lisi, P. Curci, R.M. Lemoli, S. Ballanti, R. Floris, L. Cupelli, P. Tosi, A. Olivieri, D. Rota-Scalabrini, C. Cangialosi, C. Nozzoli, B. Anaclerico, F. Fazio, B. Bruno, K. Mancuso, P. Corradini, G. Milone, M. Boccadoro
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia
2023 E. Tiacci, A. Mancini, M. Marchetti, G.M. D'Elia, A. Candoni, A. Morotti, A. Romano, A. Gozzetti, A. Broccoli, L. De Carolis, R. Bruna, M.C. Tisi, C. Selleri, M. Capponi, D. Vallisa, C. Cattaneo, M.G. Della Porta, A. Busca, B. Falini, M. Massaia, L. Bertù, A. Pulsoni, P. Rivela, P. Corradini, F. Passamonti
COVID-19 in adult acute myeloid leukemia patients: a long-term followup study from the European Hematology Association survey (EPICOVIDEHA)
2023 F. Marchesi, J. Salmanton-García, Z. Emarah, K. Piukovics, M. Nucci, A. López-García, Z. Ráčil, F. Farina, M. Popova, S. Zompi, E. Audisio, M. Ledoux, L. Verga, B. Weinbergerová, T. Szotkovski, M.G. Da Silva, N. Fracchiolla, N. De Jonge, G. Collins, M. Marchetti, G. Magliano, C. García-Vidal, M.M. Biernat, J. Van Doesum, M. Machado, F. Demirkan, M. Al-Khabori, P. Žák, B. Víšek, I. Stoma, G. Méndez, J. Maertens, N. Khanna, I. Espigado, G. Dragonetti, L. Fianchi, M.I. Del Principe, A. Cabirta, I. Ormazabal-Vélez, O. Jaksic, C. Buquicchio, V. Bonuomo, J. Batinić, A.S. Omrani, S. Lamure, O. Finizio, N. Fernández, I. Falces-Romero, O. Blennow, R. Bergantim, N. Ali, S. Win, J. Van Praet, M.C. Tisi, A. Shirinova, M. Schönlein, J. Prattes, M. Piedimonte, V. Petzer, M. Navrátil, A. Kulasekararaj, P. Jindra, J. Sramek, A. Glenthøj, R. Fazzi, C. De Ramón-Sánchez, C. Cattaneo, M. Calbacho, N.C. Bahr, S. El-Ashwah, R. Cordoba, M. Hanakova, G. Zambrotta, M. Sciumè, S. Booth, R.N. Rodrigues, M.V. Sacchi, N. García-Poutón, J. Martín-González, S. Khostelidi, S. Gräfe, L. Rahimli, E. Ammatuna, A. Busca, P. Corradini, M. Hoenigl, N. Klimko, P. Koehler, A. Pagliuca, F. Passamonti, O.A. Cornely, L. Pagano
Outcome after chimeric antigen receptor (CAR) T-cell therapy failure in large B-cell lymphomas
2023 A. Dodero, S. Bramanti, M. Di Trani, M. Pennisi, S. Ljevar, A. Chiappella, M. Massimo, A. Guidetti, F. Corrado, P.M. Nierychlewska, A. Di Rocco, D. Lorenzini, R. Daoud, C. De Philippis, A. Santoro, C. Carlo-Stella, P. Corradini
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma
2023 B. Ziccheddu, C. Giannotta, M. D'Agostino, G. Bertuglia, E. Saraci, S. Oliva, E. Genuardi, M. Papadimitriou, B. Diamond, P. Corradini, D. Coffey, O. Landgren, N. Bolli, B. Bruno, M. Boccadoro, M. Massaia, F. Maura, A. Larocca
Predictors of Unsustained Minimal Residual Disease Negativity in Multiple Myeloma (MM) Patients
2023 M. D'Agostino, G. Bertuglia, D. Rota-Scalabrini, A. Belotti, S. Morè, P. Corradini, S. Oliva, A. Ledda, M. Grasso, V. Pavone, S. Ronconi, I.D. Vincelli, S. Ballanti, C. Velluti, C. Cellini, A. Gozzetti, A.D. Palmas, B. Gamberi, K. Mancuso, L. Paris, R. Zambello, M.T. Petrucci, B. Bruno, P. Musto, F. Gay
Haematology and specialist palliative medicine education and training
2023 M. Luppi, E. Bandieri, A. Venditti, P. Corradini
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
2023 K. Rejeski, M. Subklewe, M. Aljurf, E. Bachy, A. Balduzzi, P. Barba, B. Bruno, R. Benjamin, M.G. Carrabba, C. Chabannon, F. Ciceri, P. Corradini, J. Delgado, R. Di Blasi, R. Greco, R. Houot, G. Iacoboni, U. Jäger, M.J. Kersten, S. Mielke, A. Nagler, F. Onida, Z. Peric, C. Roddie, A. Ruggeri, F. Sánchez-Guijo, I. Sánchez-Ortega, D. Schneidawind, M. Schubert, J.A. Snowden, C. Thieblemont, M. Topp, P.L. Zinzani, J.G. Gribben, C. Bonini, A. Sureda, I. Yakoub-Agha
CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma: towards a rational approach
2023 P. Dreger, P. Corradini, J.G. Gribben, B. Glass, M. Jerkeman, M.J. Kersten, F. Morschhauser, A. Mussetti, A. Viardot, P.L. Zinzani, A. Sureda
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti-CD19 chimeric antigen receptor T-cell efficacy
2023 A. Guidetti, A. Dodero, A. Lorenzoni, S. Pizzamiglio, G. Argiroffi, A. Chiappella, F. Bagnoli, V. Marasco, C. Carniti, C. Monfrini, E. Seregni, M. Pennisi, P. Verderio, A. Alessi, P. Corradini
Effectiveness and management of ponatinib as second-line treatment in chronic myeloid leukemia: an analysis from the monitoring registries of the Italian medicines agency (AIFA)
2023 M. Breccia, P.P. Olimpieri, S. Celant, O.M. Olimpieri, F. Pane, A. Iurlo, V. Summa, P. Corradini, P. Russo